Fragile X syndrome market to quadruple to $111.9 million in US and Germany by 2030, forecasts GlobalData Read more
Sun Pharma amongst top 5% of global pharma companies in S&P Global Sustainability Yearbook 2025 Read more
Duchenne muscular dystrophy market to reach $5.2 billion in 7MM by 2033, forecasts GlobalData Read more
Zydus Lifesciences partners with Zhuhai Beihai Biotech for BEIZRAY commercialisation in the US Read more
Rusan Pharma Chairman Dr Navin Saxena receives Russia’s ‘Order of Friendship’ and ‘Memorial Medal’ Read more